Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sanjay Ahuja MD, MSc, MBA

Sanjay P. Ahuja MD, MSc, MBA

Director, Hemophilia Treatment Center, University Hospitals/Rainbow Babies & Children’s Hospital; Professor of Pediatrics, Case Western Reserve University, Cleveland, Ohio

Sanjay P. Ahuja, MD, MSc, MBA, is the Clinical Director, Division of Pediatric Hematology/Oncology and Director of UH Rainbow Hemostasis & Thrombosis Center, Professor of Pediatric Hematology/oncology, Case Western Reserve University, and Dominic Piunno Endowed Chair in Hemophilia & Bleeding disorders, at the University Hospitals Rainbow Babies & Children’s Hospital in Cleveland, Ohio. Dr. Ahuja received his medical degree from Seth G S Medical College and the University of Mumbai in Mumbai, India. He did fellowship in pediatric hematology/oncology at Children’s Hospital of Pittsburgh, Pittsburgh, PA. He earned his Master in Science, Clinical Research degree from the University of Pittsburgh School Of Medicine in Pennsylvania and his Masters of Business Administration from the Weatherhead School of Management at Case Western Reserve University in Cleveland, Ohio.

Dr. Ahuja’s research interests are novel assays in bleeding and clotting disorders, and investigation of catheter-related thrombosis in children.

Disclosures

Dr. Ahuja reports the following: Scientific Advisory Board Member: Sanofi, Novo Nordisk, Bayer, Genentech; DSMB member, Takeda Oncology; Advisory Board member: Treatment outcomes, Hemophilia Federation of America; Member, Rare Disease Advisory Council, State of Ohio.